NCT05307601View on ClinicalTrials.gov

Immune Response Following COVID-19 in Hemodialysis Patients

CompletedOBSERVATIONAL

Enrollment

21

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

September 1, 2021

Study Completion Date

October 30, 2021

Conditions

Dialysis; ComplicationsCOVID-19Cytokine Storm

Trial Locations (1)

75014

AURA Paris, Paris

All Listed Sponsors

lead

AURA Paris

OTHER

NCT05307601 - Immune Response Following COVID-19 in Hemodialysis Patients | Biotech Hunter | Biotech Hunter